New Research Poster Presentation 5.33
The Pharmacokinetic Properties of a Novel Extended-Release Oral Disintegrating Tablet Formulation of Methylphenidate in Children and Adolescents With ADHD

Friday, October 30, 2015 12:30 PM
Ann Catherine Childress, MD, Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
Jeffrey G. Stark, PhD, Worldwide Clinical Trials, Austin, TX
Russ McMahen, NEOS Therapeutics Inc., Grand Prairie, TX
Mark Tengler, NEOS Therapeutics Inc., Grand Prairie, TX
Carolyn R. Sikes, PhD, Clinical Affairs, NEOS Therapeutics Inc., Grand Prairie, TX
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.